Churchill Management Corp Biogen Inc. Transaction History

Churchill Management Corp

  • $8.64 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 12, 2019
SELL
$216.71 - $338.96 $1.38 Million - $2.16 Million
-6,366 Closed
0 $0
Q4 2018

Jan 15, 2019
SELL
$278.5 - $352.75 $515,225 - $652,587
-1,850 Reduced 22.52%
6,366 $1.92 Million
Q3 2018

Oct 05, 2018
BUY
$293.51 - $383.83 $2.41 Million - $3.15 Million
8,216 New
8,216 $2.9 Million

Others Institutions Holding BIIB

# of Institutions
1,018
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Churchill Management Corp Portfolio

Follow Churchill Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Churchill Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Churchill Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email